SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere ® Microspheres are now ...
Leading manufacturer and marketer of proprietary disposable devices, Merit Medical Systems, Inc. MMSI recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres ...
Merit Medical Systems MMSI has secured a major regulatory milestone with the CE Mark approval of its Embosphere Microspheres for genicular artery embolisation (GAE) to treat knee osteoarthritis (OA).
Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results